Assessment of the Flow Cytometry Markets and User Perspective in the US
Situation
Our Client wanted to to obtain insights from experts who had experience in the flow cytometry products market as an end-user at major pharmaceutical companies and research labs.
Objective
The client sought to develop insights on the some of the challenges users experience with flow cytometry instrumentation and related software. They also wanted to gain market receptiveness for a new cloud-based software solution.
Our Work
10EQS explored the strengths and weaknesses of nine widely used flow cytometry software applications including those embedded with instrumentation and applications used for analysis. 10EQS further assessed variables in flow cytometry analysis, challenges, needs for cloud-based software, and the expected growth and market size in the US.
Project team
- Ex-EY Management Consultant with strong experience in healthcare and medical devices
- Associate Collaboration Manager who assisted with the secondary research & content synthesis
- 10EQS Delivery Operations (=PMO) provided quality assurance, process management and expert recruitment
- 5 industry experts based in the US
Industry experts (excerpt)
- Scientist – Flow Cytometry, Major University
- Scientist – Flow Cytometry
- Senior Flow Cytometry Manager, Clinical Biomarkers and Diagnostics – Large Pharma Company
- Research Scientist II – Large Pharma Company
- Flow Core Manager – Large Pharma Company
- Flow Cytometer Manager – Major University
Results
10EQS found that the flow cytometry market is expected to experience robust growth primarily due to high cancer prevalence and extensive R&D initiatives. 10EQS identified the hardware and software used per company and provided detailed comparisons across the key vendors.